Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
about
New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitorsHospital epidemiology and infection control in acute-care settings."Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.Klebsiella Pneumoniae in Septicemic Neonates with Special Reference to Extended Spectrum β-lactamase, AmpC, Metallo β-lactamase Production and Multiple Drug Resistance in Tertiary Care HospitalCombination therapy for treatment of infections with gram-negative bacteria.Prevalence and risk factor analysis of resistant Escherichia coli urinary tract infections in the emergency department.Peptides as the next generation of anti-infectives.Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram.Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.Multicenter evaluation of a new shortened peptide nucleic acid fluorescence in situ hybridization procedure for species identification of select Gram-negative bacilli from blood cultures.Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae.Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study.Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.Antibacterial activity of some medicinal plants against selected human pathogenic bacteria.In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients.Beginning and possibly the end of the antibiotic era.Why is antimicrobial de-escalation under-prescribed for urinary tract infections?Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
P2860
Q28475848-3FDB1648-35F5-4289-A496-AEC9F03AAE21Q30429049-40330164-E1EB-4D20-8A7E-C3CD32EA545BQ33648238-0E8772CB-CF0B-41E5-91FA-E729B12BA13FQ34875817-1BCFC578-11BA-448A-A390-F8F7E729F558Q35544881-1E66C5CD-9F03-4D8B-BAB7-7F2B9AF23A24Q36156077-2045C8DC-0946-46CD-A650-74F4FCB53531Q37233393-2F997213-6836-4E9A-94BC-288C81237D31Q38086871-EDD4FE8B-0200-4E55-B960-30EF4E833FF1Q39913999-51129C31-00FD-4E04-8D95-EF6FFD63E5B8Q40500618-22666673-22BB-4888-A7F7-2BC3BDE07A0BQ41017061-82494779-AF0F-4DFF-A59A-2475B3829740Q41215201-4A171780-E68B-4A6A-82A2-9B64B4068B88Q41446800-9D15C685-3C01-4724-82D2-828F16285D1FQ41476001-8420BB43-361F-44CB-9D3E-7863B62505C4Q41870412-9ED4891E-FF9E-498A-B27E-DB2EBC96DB71Q41884675-5F4FB050-5F63-474E-853C-1CF51F8AED0DQ42111661-ABA3111F-4CF1-4307-A533-063E3D64C01AQ42242524-A6EC505A-FC61-4634-BD7E-E8AD2DE183AAQ44884892-C5610B69-1502-439F-BFD5-F7121A43BC0DQ48333800-2777A176-4B68-402B-9683-742A13E4A5AAQ54324315-F5797F5C-9065-48B7-A6CC-DAEED72A1CF6Q54373146-EB443CF2-A713-4118-97F3-EE65541FF1E8
P2860
Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@en
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@nl
type
label
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@en
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@nl
prefLabel
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@en
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@nl
P2860
P356
P1476
Impact of antibiotic resistanc ...... definitive antibiotic therapy.
@en
P2860
P304
P356
10.1086/590062
P407
P478
47 Suppl 1
P577
2008-09-01T00:00:00Z